$SGRY
Surgery Partners, Inc.

2024 Q4 Form 10-Q Financial Statement

#000163883324000147 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $770.4M
YoY Change 14.29%
Cost Of Revenue $569.0M
YoY Change 16.79%
Gross Profit $201.4M
YoY Change 7.76%
Gross Profit Margin 26.14%
Selling, General & Admin $53.10M
YoY Change -8.29%
% of Gross Profit 26.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $50.20M
YoY Change 73.7%
% of Gross Profit 24.93%
Operating Expenses $709.5M
YoY Change 19.95%
Operating Profit $60.90M
YoY Change -26.27%
Interest Expense -$50.00M
YoY Change 0.4%
% of Operating Profit -82.1%
Other Income/Expense, Net $700.0K
YoY Change -41.67%
Pretax Income $10.90M
YoY Change -66.77%
Income Tax $4.500M
% Of Pretax Income 41.28%
Net Earnings -$31.70M
YoY Change 546.94%
Net Earnings / Revenue -4.11%
Basic Earnings Per Share -$0.25
Diluted Earnings Per Share -$0.25
COMMON SHARES
Basic Shares Outstanding 127.1M shares 127.1M shares
Diluted Shares Outstanding 126.2M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $221.8M
YoY Change -6.02%
Cash & Equivalents $221.8M
Short-Term Investments
Other Short-Term Assets $143.9M
YoY Change 96.32%
Inventory $82.00M
Prepaid Expenses $45.20M
Receivables $542.9M
Other Receivables $0.00
Total Short-Term Assets $1.036B
YoY Change 18.22%
LONG-TERM ASSETS
Property, Plant & Equipment $1.302B
YoY Change 9.95%
Goodwill $4.815B
YoY Change 13.43%
Intangibles
YoY Change
Long-Term Investments $214.8M
YoY Change 9.42%
Other Assets $41.10M
YoY Change -64.99%
Total Long-Term Assets $6.499B
YoY Change 10.07%
TOTAL ASSETS
Total Short-Term Assets $1.036B
Total Long-Term Assets $6.499B
Total Assets $7.534B
YoY Change 11.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $170.8M
YoY Change 14.78%
Accrued Expenses $250.0M
YoY Change 12.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $97.30M
YoY Change 56.68%
Total Short-Term Liabilities $575.2M
YoY Change 14.72%
LONG-TERM LIABILITIES
Long-Term Debt $3.094B
YoY Change 17.2%
Other Long-Term Liabilities $30.30M
YoY Change -61.6%
Total Long-Term Liabilities $30.30M
YoY Change -61.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $575.2M
Total Long-Term Liabilities $30.30M
Total Liabilities $605.5M
YoY Change 4.34%
SHAREHOLDERS EQUITY
Retained Earnings -$628.8M
YoY Change 10.67%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.897B
YoY Change
Total Liabilities & Shareholders Equity $7.534B
YoY Change 11.13%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$31.70M
YoY Change 546.94%
Depreciation, Depletion And Amortization $50.20M
YoY Change 73.7%
Cash From Operating Activities $65.20M
YoY Change -37.67%
INVESTING ACTIVITIES
Capital Expenditures $20.20M
YoY Change 6.88%
Acquisitions
YoY Change
Other Investing Activities -$29.40M
YoY Change 338.81%
Cash From Investing Activities -$49.60M
YoY Change 93.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.300M
YoY Change -64.22%
NET CHANGE
Cash From Operating Activities 65.20M
Cash From Investing Activities -49.60M
Cash From Financing Activities -7.300M
Net Change In Cash 8.300M
YoY Change -85.84%
FREE CASH FLOW
Cash From Operating Activities $65.20M
Capital Expenditures $20.20M
Free Cash Flow $45.00M
YoY Change -47.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
496400000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
82000000.0 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
75200000 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
45200000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
31000000.0 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
143900000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
96500000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1035800000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
895000000.0 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
558800000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
454400000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1004500000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
968700000 usd
CY2024Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
4861500000 usd
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
4380800000 usd
CY2024Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
214800000 usd
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
184100000 usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
126593727 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126593727 shares
CY2024Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1300000 usd
CY2023Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1300000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2513500000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2497600000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
10500000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
57500000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-628800000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-569200000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1896500000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7534400000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6876700000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
770400000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
674100000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2249900000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2007900000 usd
CY2024Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
228400000 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
195000000.0 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
666800000 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
592400000 usd
CY2024Q3 us-gaap Supplies Expense
SuppliesExpense
201400000 usd
us-gaap Supplies Expense
SuppliesExpense
589900000 usd
us-gaap Supplies Expense
SuppliesExpense
549800000 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
91000000.0 usd
CY2023Q3 sgry Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
21100000 usd
sgry Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
67500000 usd
sgry Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
64300000 usd
CY2024Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
48200000 usd
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
40600000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
147700000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
127600000 usd
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
592900000 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
508300000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1737900000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1554000000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
29200000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36800000 usd
us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-10700000 usd
us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-3200000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
709500000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
591500000 usd
us-gaap Operating Expenses
OperatingExpenses
2028200000 usd
us-gaap Operating Expenses
OperatingExpenses
1781300000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
60900000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
82600000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
221700000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
226600000 usd
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-50000000.0 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-49800000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-148800000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-144300000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
10900000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
32800000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
72900000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
82300000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4500000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3100000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13800000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6300000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
6400000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
29700000 usd
us-gaap Profit Loss
ProfitLoss
59100000 usd
us-gaap Profit Loss
ProfitLoss
88600000 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
38100000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
34600000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
118700000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
99500000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-31700000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4900000 usd
us-gaap Net Income Loss
NetIncomeLoss
-59600000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10900000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126172000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126093000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125559000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126172000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125747000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126093000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125559000 shares
CY2024Q3 us-gaap Profit Loss
ProfitLoss
6400000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
29700000 usd
us-gaap Profit Loss
ProfitLoss
59100000 usd
us-gaap Profit Loss
ProfitLoss
88600000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
0 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
27900000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
12100000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
89400000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
38100000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
34600000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
118700000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
99500000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58300000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6700000 usd
CY2024Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
29700000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3037900000 usd
CY2024Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
20000000.0 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15100000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-14900000 usd
CY2024Q2 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
147800000 usd
CY2024Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
29600000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3176300000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2940900000 usd
CY2023Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-6700000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3700000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
30200000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2942500000 usd
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Surgery Partners, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3620923
dei Entity Address Address Line1
EntityAddressAddressLine1
340 Seven Springs Way, Suite 600
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
SGRY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
127113514 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
221800000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
195900000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
542900000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
297500000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
255300000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
79200000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
89500000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
41100000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
103300000 usd
CY2024Q3 us-gaap Assets
Assets
7534400000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
170800000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
171800000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
64900000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
73800000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
242200000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
204100000 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
97300000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
73300000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
575200000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
523000000.0 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3094200000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2701800000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
286400000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
248900000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
30300000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
41100000 usd
CY2024Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
436400000 usd
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
327400000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20310000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20310000 shares
CY2024Q3 us-gaap Minority Interest
MinorityInterest
1215400000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
1047300000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3111900000 usd
CY2023Q3 us-gaap Supplies Expense
SuppliesExpense
179200000 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
72400000 usd
us-gaap Professional Fees
ProfessionalFees
266000000.0 usd
us-gaap Professional Fees
ProfessionalFees
219900000 usd
CY2024Q3 sgry Operating And Finance Lease Expense
OperatingAndFinanceLeaseExpense
23900000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
102700000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
100000000.0 usd
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
50200000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28900000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
118700000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
87000000.0 usd
CY2024Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
29400000 usd
CY2023Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
12800000 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
66100000 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
37300000 usd
CY2024Q3 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-2200000 usd
CY2023Q3 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
-1200000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125747000 shares
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1800000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-47000000.0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
800000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-20200000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-106600000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10100000 usd
CY2024Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
16900000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4900000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5500000 usd
CY2024Q1 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
16800000 usd
CY2024Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
3000000.0 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7000000.0 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-26600000 usd
CY2024Q3 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
-16300000 usd
CY2024Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
31500000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3111900000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11300000 usd
CY2023Q1 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
46100000 usd
CY2023Q2 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
46600000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4500000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13900000 usd
CY2023Q2 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
-900000 usd
CY2023Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
23800000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2982800000 usd
CY2023Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
23100000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4500000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1800000 usd
CY2023Q3 sgry Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net
NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet
1700000 usd
CY2023Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
23800000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2986500000 usd
us-gaap Profit Loss
ProfitLoss
59100000 usd
us-gaap Profit Loss
ProfitLoss
88600000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
87000000.0 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
29200000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
26400000 usd
sgry Noncash Interest Income Expense Net
NoncashInterestIncomeExpenseNet
-4800000 usd
sgry Noncash Interest Income Expense Net
NoncashInterestIncomeExpenseNet
-19800000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
27100000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
13200000 usd
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-21500000 usd
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-7500000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
282900000 usd
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
19200000 usd
sgry Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests
RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests
121400000 usd
sgry Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders
RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
31600000 usd
CY2024Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
436400000 usd
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
723600000 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
693600000 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
34100000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
27100000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
2775100000 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
97300000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
73300000 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3094200000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
2701800000 usd
CY2024Q3 sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
128600000 usd
CY2023Q3 sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
105500000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
10900000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
32800000 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
38100000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
34600000 usd
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-50000000.0 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-49800000 usd
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
50200000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28900000 usd
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
7100000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
4400000 usd
CY2024Q3 sgry Business Combination Integration Related Costs And Merger Costs
BusinessCombinationIntegrationRelatedCostsAndMergerCosts
31500000 usd
CY2023Q3 sgry Business Combination Integration Related Costs And Merger Costs
BusinessCombinationIntegrationRelatedCostsAndMergerCosts
13000000.0 usd
CY2023Q3 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-5800000 usd
CY2024Q3 sgry Gain Loss Related To Litigation Settlement And Regulatory Change Impact
GainLossRelatedToLitigationSettlementAndRegulatoryChangeImpact
-1600000 usd
CY2023Q3 sgry Gain Loss Related To Litigation Settlement And Regulatory Change Impact
GainLossRelatedToLitigationSettlementAndRegulatoryChangeImpact
-4200000 usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Small Business
EntitySmallBusiness
false
CY2023Q4 us-gaap Assets
Assets
6876700000 usd
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
127127901 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
127127901 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3034500000 usd
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-14700000 usd
CY2023Q3 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-5800000 usd
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-21500000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5200000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3500000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
12300000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9400000 usd
CY2024Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-500000 usd
CY2023Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-3600000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
800000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-8100000 usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5100000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
0 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
0 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-26600000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3034500000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001638833
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2023Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2024Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2024Q3 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations
CY2023Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations
CY2024Q3 us-gaap Oci Cash Flow Hedge Reclassification For Discontinuance Statement Of Income Or Comprehensive Income Extensible Enumeration
OciCashFlowHedgeReclassificationForDiscontinuanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet
CY2023Q3 us-gaap Oci Cash Flow Hedge Reclassification For Discontinuance Statement Of Income Or Comprehensive Income Extensible Enumeration
OciCashFlowHedgeReclassificationForDiscontinuanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet
us-gaap Oci Cash Flow Hedge Reclassification For Discontinuance Statement Of Income Or Comprehensive Income Extensible Enumeration
OciCashFlowHedgeReclassificationForDiscontinuanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet
us-gaap Oci Cash Flow Hedge Reclassification For Discontinuance Statement Of Income Or Comprehensive Income Extensible Enumeration
OciCashFlowHedgeReclassificationForDiscontinuanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1987200000 usd
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-7500000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
118700000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5100000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
10300000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10800000 usd
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-300000 usd
us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
2700000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31200000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18200000 usd
sgry Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants
IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants
0 usd
sgry Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants
IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants
-1200000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
56200000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-21600000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
188700000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
231200000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
68100000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
69000000.0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
291200000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
48800000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1500000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
25800000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1700000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
50200000 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
4000000.0 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
1000000.0 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
21300000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
26300000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-376800000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-167500000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1108800000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
107100000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1463800000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
119400000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
15100000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1500000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
122400000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
111000000.0 usd
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
5600000 usd
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
700000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-9100000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-11100000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
214000000.0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-110600000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25900000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-46900000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
195900000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
221800000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
236000000.0 usd
CY2024Q3 sgry Number Of Surgical Facilities Owned
NumberOfSurgicalFacilitiesOwned
166 facility
CY2024Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
33 state
CY2024Q3 sgry Number Of Surgical Facilities Owned Majority Interest
NumberOfSurgicalFacilitiesOwnedMajorityInterest
89 facility
CY2024Q3 sgry Number Of Surgical Facilities Owned Consolidated
NumberOfSurgicalFacilitiesOwnedConsolidated
123 facility
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain prior year amounts have been reclassified to conform with the current year presentation.
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</span></div>
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
770400000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
674100000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2249900000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2007900000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.189
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.077
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
1500000 usd
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-1600000 usd
us-gaap Income Tax Reconciliation Disposition Of Business
IncomeTaxReconciliationDispositionOfBusiness
-15800000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
4326000000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
495400000 usd
us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
6000000.0 usd
CY2024Q3 us-gaap Goodwill
Goodwill
4815400000 usd
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
327400000 usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
342000000.0 usd
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
25600000 usd
sgry Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests
RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests
-2200000 usd
sgry Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders
RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
33200000 usd
CY2023Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
332200000 usd
CY2024Q3 sgry Variable Interest Entity Number Of Facilities
VariableInterestEntityNumberOfFacilities
9 facility
CY2024Q3 sgry Variable Interest Entity Number Of Facilities
VariableInterestEntityNumberOfFacilities
26 physician_practice
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-10000000 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
3191500000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
297500000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
255300000 usd
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
588600000 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
587000000.0 usd
CY2024Q3 sgry Lease Right Of Use Asset
LeaseRightOfUseAsset
886100000 usd
CY2023Q4 sgry Lease Right Of Use Asset
LeaseRightOfUseAsset
842300000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41400000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
37600000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
286400000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
248900000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
327800000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
286500000 usd
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
29500000 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
25400000 usd
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
694100000 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
668200000 usd
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
723600000 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
693600000 usd
CY2024Q3 sgry Lease Liability
LeaseLiability
1051400000 usd
CY2023Q4 sgry Lease Liability
LeaseLiability
980100000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
50100000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
48700000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
47500000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
29000000.0 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
40600000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
35900000 usd
sgry Finance Lease Cost
FinanceLeaseCost
88100000 usd
sgry Finance Lease Cost
FinanceLeaseCost
64900000 usd
sgry Variable And Short Term Lease Cost
VariableAndShortTermLeaseCost
18100000 usd
sgry Variable And Short Term Lease Cost
VariableAndShortTermLeaseCost
16300000 usd
us-gaap Lease Cost
LeaseCost
156300000 usd
us-gaap Lease Cost
LeaseCost
129900000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
48000000.0 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
47200000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
38600000 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
34100000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
24400000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
19300000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
79300000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
39900000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
40800000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
108700000 usd
CY2024Q3 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
2739900000 usd
CY2023Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
1360100000 usd
us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
19000000.0 usd
CY2024Q3 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
21700000 usd
CY2024Q3 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
18400000 usd
CY2023Q4 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
57400000 usd
CY2023Q4 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
17800000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
5300000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
16000000.0 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-31700000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4900000 usd
us-gaap Net Income Loss
NetIncomeLoss
-59600000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10900000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126172000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125747000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126093000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
125559000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126172000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125747000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
126093000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
125559000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41400000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
37600000 usd
CY2024Q3 sgry Cost Report Liabilities Current
CostReportLiabilitiesCurrent
20700000 usd
CY2023Q4 sgry Cost Report Liabilities Current
CostReportLiabilitiesCurrent
23900000 usd
CY2024Q3 srt Payables To Customers
PayablesToCustomers
29400000 usd
CY2023Q4 srt Payables To Customers
PayablesToCustomers
23900000 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
29900000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
17800000 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
7000000.0 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
113800000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
100900000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
242200000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
204100000 usd
CY2024Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
18100000 usd
CY2023Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
18200000 usd
CY2024Q3 us-gaap Estimated Insurance Recoveries
EstimatedInsuranceRecoveries
10200000 usd
CY2023Q4 us-gaap Estimated Insurance Recoveries
EstimatedInsuranceRecoveries
10200000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
770400000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
674100000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2249900000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2007900000 usd
sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
344400000 usd
sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
295800000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
72900000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
82300000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
118700000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
99500000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-148800000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-144300000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
118700000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
87000000.0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
27100000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
13200000 usd
sgry Business Combination Integration Related Costs And Merger Costs
BusinessCombinationIntegrationRelatedCostsAndMergerCosts
71200000 usd
sgry Business Combination Integration Related Costs And Merger Costs
BusinessCombinationIntegrationRelatedCostsAndMergerCosts
38800000 usd
CY2024Q3 sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-14700000 usd
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-21500000 usd
sgry Gain Loss On Disposition Of Assets And Deconsolidation
GainLossOnDispositionOfAssetsAndDeconsolidation
-7500000 usd
sgry Gain Loss Related To Litigation Settlement And Regulatory Change Impact
GainLossRelatedToLitigationSettlementAndRegulatoryChangeImpact
-1500000 usd
sgry Gain Loss Related To Litigation Settlement And Regulatory Change Impact
GainLossRelatedToLitigationSettlementAndRegulatoryChangeImpact
-13900000 usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5100000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q3 sgry Undesignated Derivative Activity
UndesignatedDerivativeActivity
0 usd
CY2023Q3 sgry Undesignated Derivative Activity
UndesignatedDerivativeActivity
0 usd
sgry Undesignated Derivative Activity
UndesignatedDerivativeActivity
0 usd
sgry Undesignated Derivative Activity
UndesignatedDerivativeActivity
-600000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
700000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1200000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3700000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7700000 usd
CY2024Q3 sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
128600000 usd
CY2023Q3 sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
105500000 usd
sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
344400000 usd
sgry Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
295800000 usd
CY2024Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
29400000 usd
CY2023Q3 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
12800000 usd
CY2024Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2100000 usd
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
200000 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
66100000 usd
us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
37300000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
5100000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1500000 usd
CY2024Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-500000 usd
CY2023Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-3600000 usd
CY2024Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1100000 usd
CY2023Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
600000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
800000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-8100000 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
2300000 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1400000 usd
sgry Interest Expense Impact Of Change In Letter Of Protection Regulation
InterestExpenseImpactOfChangeInLetterOfProtectionRegulation
4400000 usd
CY2024Q3 us-gaap Assets
Assets
7534400000 usd
CY2023Q4 us-gaap Assets
Assets
6876700000 usd
us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
68100000 usd
us-gaap Segment Expenditure Addition To Long Lived Assets
SegmentExpenditureAdditionToLongLivedAssets
69000000.0 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001638833-24-000147-index-headers.html Edgar Link pending
0001638833-24-000147-index.html Edgar Link pending
0001638833-24-000147.txt Edgar Link pending
0001638833-24-000147-xbrl.zip Edgar Link pending
a2024q3exhibit311.htm Edgar Link pending
a2024q3exhibit312.htm Edgar Link pending
a2024q3exhibit321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sgry-20240930.htm Edgar Link pending
sgry-20240930.xsd Edgar Link pending
sgry-20240930_g1.jpg Edgar Link pending
Show.js Edgar Link pending
sgry-20240930_def.xml Edgar Link unprocessable
sgry-20240930_lab.xml Edgar Link unprocessable
sgry-20240930_pre.xml Edgar Link unprocessable
sgry-20240930_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
sgry-20240930_cal.xml Edgar Link unprocessable